B.O'Mahony^1,2; J.Mahlangu³; K.Peerlinck⁴; JDWang⁵; G.Lowe⁶; CWTan⁷; A.Giermasz⁸; H.Tran⁹; TLKhoo¹⁰; E.Cockrell¹¹; D.Pepperell¹²; H.Chambost¹³; MFLernández¹⁴; R.Kazmi¹⁵; E.Majerus¹⁶; MWSkinner^17,18; R.Klamroth¹⁹; J.Quinn²⁰; H.Yu²⁰; WYWong²⁰; A.Lawal²⁰; TMRobinson²⁰; B.Kim²⁰

¹Soċjetà Irlandiża tal-Emofilja;²Trinity College, Dublin, l-Irlanda;³ Emophilia Comprehensive Care Center, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand u NHLS, Johannesburg, Afrika t'Isfel;⁴ Dipartiment tal-Mediċina Vaskulari u Emostasi u Emofilja Ċentru, Sptarijiet Universitarji Leuven, Leuven, il-Belġju;⁵ Centerfor Rare Disease and Hemophilia, Taichung Veterans General Hospital, Taichung, Tajwan, Provinċja taċ-Ċina;⁶ West Midlands Comprehensive Care Haemophilia Centre, Queen Elizabeth Hospital, Birmingham, ir-Renju Unit;⁷ Dipartiment tal-Ematoloġija, Royal Adelaide Hospital, Adelaide, l-Awstralja;⁸ Ċentru ta 'Trattament tal-Emofilja, Università ta' California Davis, Sacramento, l-Istati Uniti;⁹ Haemostasis & Thrombosis Unit, Emophilia Treatment Centre, The Alfred Hospital, Melbourne;¹⁰ Istitut tal-Ematoloġija, Royal Prince Alfred Hospital, Camperdown, l-Awstralja;¹¹ Onkoloġija tal-Ematoloġija Pedjatrika, Saint Joseph's Children's Hospital, Tampa, l-Istati Uniti;¹² Dipartiment tal-Ematoloġija, Fiona Stanley Hospital, Murdoch, l-Awstralja;¹³ AP-HM, Dipartiment tal-Onkoloġija tal-Ematoloġija Pedjatrika, l-Isptar tat-Tfal La Timone, Università ta 'Aix Marseille, INSERM, INRA, C2VN, Marsilja, Franza;¹⁴ Complejo Hospitalario Universitario A Coruña, A Coruña, Spanja;¹⁵ Dipartiment tal-Ematoloġija, Southampton University Hospital, Southampton, ir-Renju Unit;¹⁶ Dipartiment tal-Mediċina, Washington University f'St Louis, St.¹⁷ Institute for Policy Advancement Ltd, Washington, l-Istati Uniti;¹⁸ McMaster University, Hamilton, Kanada;¹⁹ Ċentru għat-Trattament tal-Emofilja tal-Kura Komprensiva, Vivantes Klinikumim Friedrichshain, Berlin, il-Ġermanja;²⁰ BioMarin Pharmaceutical Inc., Novato, l-Istati Uniti